MCL1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 7.630600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
9.875800E-01
Normal-vs-Stage2
6.763400E-01
Normal-vs-Stage3
1.667830E-01
Normal-vs-Stage4
1.458830E-01
Stage1-vs-Stage2
5.460200E-01
Stage1-vs-Stage3
2.194800E-01
Stage1-vs-Stage4
8.504300E-02
Stage2-vs-Stage3
1.297030E-01
Stage2-vs-Stage4
1.586970E-01
Stage3-vs-Stage4
2.109800E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
7.791800E-01
Normal-vs-AfricanAmerican
3.745000E-01
Normal-vs-Asian
5.854200E-01
Caucasian-vs-AfricanAmerican
8.790400E-02
Caucasian-vs-Asian
1.869790E-01
AfricanAmerican-vs-Asian
1.387850E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
8.498200E-01
Normal-vs-Female
6.593800E-01
Male-vs-Female
3.524800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
7.781200E-01
Normal-vs-Age(41-60Yrs)
4.299600E-01
Normal-vs-Age(61-80Yrs)
9.439000E-01
Normal-vs-Age(81-100Yrs)
7.497600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
2.948000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
6.844400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
9.479000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
3.356100E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
5.373700E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
5.004800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
8.681600E-01
Normal-vs-Daily Drinker
9.492400E-01
Normal-vs-Weekly Drinker
6.458600E-01
Normal-vs-Occasional Drinker
7.797600E-01
Normal-vs-Social Drinker
8.634600E-01
Non Drinker-vs-Daily Drinker
6.338400E-01
Non Drinker-vs-Weekly Drinker
4.526000E-01
Non Drinker-vs-Occasional Drinker
7.380400E-01
Non Drinker-vs-Social Drinker
9.771200E-01
Daily Drinker-vs-Weekly Drinker
3.108800E-01
Daily Drinker-vs-Occasional Drinker
4.979800E-01
Daily Drinker-vs-Social Drinker
6.760200E-01
Weekly Drinker-vs-Occasional Drinker
7.211200E-01
Weekly Drinker-vs-Social Drinker
5.508200E-01
Occasional Drinker-vs-Social Drinker
8.024200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
4.534600E-01
Normal-vs-Grade 2
6.356300E-02
Normal-vs-Grade 3
5.801600E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
4.504300E-02
Grade 1-vs-Grade 3
1.017350E-01
Grade 1-vs-Grade 4
4.534600E-01
Grade 2-vs-Grade 3
5.907400E-01
Grade 2-vs-Grade 4
6.356300E-02
Grade 3-vs-Grade 4
5.801600E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
8.870200E-01
Normal-vs-NonDiabetic
8.516400E-01
Diabetic-vs-NonDiabetic
8.833800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
4.557000E-01
Normal-vs-NoPancreatitis
8.561000E-01
Pancreatitis-vs-NoPancreatitis
4.821200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
8.159400E-01
Normal-vs-N1
6.953200E-01
N0-vs-N1
5.089400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
8.007200E-01
Normal-vs-TP53-NonMutant
5.535600E-01
TP53-Mutant-vs-TP53-NonMutant
2.365000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
